These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10353456)

  • 1. A puzzling case of seizures and visual hallucinations during clomipramine treatment with a high dose but causing a low serum concentration.
    Terao T; Ohmori O; Shinkai T
    Acta Psychiatr Scand; 1999 May; 99(5):388-90; discussion 390-2. PubMed ID: 10353456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Citalopram: an interaction study with clomipramine in a patient heterozygous for CYP2D6 genotype.
    Haffen E; Vandel P; Broly F; Vandel S; Sechter D; Bizouard P; Bechtel PR
    Pharmacopsychiatry; 1999 Nov; 32(6):232-4. PubMed ID: 10599932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic fluvoxamine-clomipramine interaction with favorable therapeutic consequences in therapy-resistant depressive patient.
    Conus P; Bondolfi G; Eap CB; Macciardi F; Baumann P
    Pharmacopsychiatry; 1996 May; 29(3):108-10. PubMed ID: 8738315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Status epilepticus associated with the combination of valproic acid and clomipramine.
    DeToledo JC; Haddad H; Ramsay RE
    Ther Drug Monit; 1997 Feb; 19(1):71-3. PubMed ID: 9029750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum clomipramine and desmethylclomipramine levels in a CYP2C19 and CYP2D6 intermediate metabolizer.
    Brown JT; Schneiderhan M; Eum S; Bishop JR
    Pharmacogenomics; 2017 May; 18(7):601-605. PubMed ID: 28470111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrarapid metabolism of clomipramine in a therapy-resistant depressive patient, as confirmed by CYP2 D6 genotyping.
    Baumann P; Broly F; Kosel M; Eap CB
    Pharmacopsychiatry; 1998 Mar; 31(2):72. PubMed ID: 9562213
    [No Abstract]   [Full Text] [Related]  

  • 7. Clomipramine, fluoxetine and CYP2D6 metabolic capacity in depressed patients.
    Vandel P; Haffen E; Nezelof S; Broly F; Kantelip JP; Sechter D
    Hum Psychopharmacol; 2004 Jul; 19(5):293-8. PubMed ID: 15252821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tricyclic antidepressant plasma levels after fluoxetine addition.
    Vandel S; Bertschy G; Bonin B; Nezelof S; François TH; Vandel B; Sechter D; Bizouard P
    Neuropsychobiology; 1992; 25(4):202-7. PubMed ID: 1454161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Interaction between paroxetine and clomipramine as a possible reason for admission to a department of internal medicine].
    Skjelbo EF; Brøsen K
    Ugeskr Laeger; 1998 Sep; 160(39):5665-6. PubMed ID: 9771062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic drug monitoring of tricyclic antidepressants in everyday clinical practice.
    Pfuhlmann B; Gerlach M; Burger R; Gonska S; Unterecker S; Jabs B; Riederer P; Deckert J
    J Neural Transm Suppl; 2007; (72):287-96. PubMed ID: 17982905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Musical hallucinations triggered by clomipramine?
    Vallada HP; Gentil V
    Br J Psychiatry; 1991 Dec; 159():888-9. PubMed ID: 1790470
    [No Abstract]   [Full Text] [Related]  

  • 12. Interaction of modafinil and clomipramine as comedication in a narcoleptic patient.
    Grözinger M; Härtter S; Hiemke C; Griese EU; Röschke J
    Clin Neuropharmacol; 1998; 21(2):127-9. PubMed ID: 9579300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Grapefruit juice as a contraindication? An approach in psychiatry].
    Vandel P; Regina W; Reix I; Vandel S; Sechter D; Bizouard P
    Encephale; 1999; 25(1):67-71. PubMed ID: 10205736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Citalopram pharmacokinetic interaction with clomipramine. UDP-glucuronosyltransferase inhibition? A case report.
    Haffen E; Vandel P; Bonin B; Vandel S
    Therapie; 1999; 54(6):768-70. PubMed ID: 10709456
    [No Abstract]   [Full Text] [Related]  

  • 15. [Seizure occurring during treatment with antidepressive agents].
    Rasmussen BK
    Ugeskr Laeger; 1987 Nov; 149(48):3258-9. PubMed ID: 3433527
    [No Abstract]   [Full Text] [Related]  

  • 16. Neonatal convulsions caused by withdrawal from maternal clomipramine.
    Cowe L; Lloyd DJ; Dawling S
    Br Med J (Clin Res Ed); 1982 Jun; 284(6332):1837-8. PubMed ID: 6805722
    [No Abstract]   [Full Text] [Related]  

  • 17. Adverse drug reactions following nonresponse in a depressed patient with CYP2D6 deficiency and low CYP 3A4/5 activity.
    Stephan PL; Jaquenoud Sirot E; Mueller B; Eap CB; Baumann P
    Pharmacopsychiatry; 2006 Jul; 39(4):150-2. PubMed ID: 16871470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of HPLC with silica-phase and reversed-phase eluents for the determination of clomipramine and demethylated and 8-hydroxylated metabolites.
    Coudoré F; Hourcade F; Molinier-Manoukian C; Eschalier A; Lavarenne J
    J Anal Toxicol; 1996; 20(2):101-5. PubMed ID: 8868400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hematological changes and antidepressive treatment].
    Ràfols Crestani A; García Vicente JA
    Aten Primaria; 1999 Feb; 23(3):179-80. PubMed ID: 10095290
    [No Abstract]   [Full Text] [Related]  

  • 20. Preliminary observations of the significance of monitoring tricyclic antidepressant plasma levels in the pediatric patient.
    Dugas M; Zarifian E; Leheuzey MF; Rovei V; Durand G; Morselli PL
    Ther Drug Monit; 1980; 2(4):307-14. PubMed ID: 7222184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.